RE:RE:RE:RE:RE:New Press Release - Theralase(R) Releases 1Q2023 Interim Financial Statements You are correct. But that peculiar approach to the data is entirely misleading, and – I would argue -- perverse and subversive.
The string of greens – followed by a string of reds – can give rise to the following immediate and speculative responses:
1. Holy cow! It looks as though everything was hunky-dory. Then they ran into a problem!
2. What happened? I thought that TLD stuff had been tested for shelf life! Did they run into a bad batch? Is there something here we haven’t been told about?
3. Do all those reds represent the results from sites that are incompetent?
4. Why does the company continually appear to wish to obfuscate rather than clarify? Does the person in charge of data presentation have deep-seated, underlying psychological issues? Feels the need to over-organize in order to prove competence? Is simply mindlessly indifferent to the implications? Gets a kick out of watching the confusion – for days or weeks – which follows each release of data?
We know -- in fact – that the first 12 patients were under-treated. There was no initial period of hunky-doriness – followed by disaster. The swimmer’s plot should reflect that reality. The fact that it does not is – to be kind – “troubling.”